02181.HK_Providing professional financial news and data related to 02181.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Mabpharm-B (02181.HK) CMAB807X Denosumab Injection NDA Approved by NMPA

Tags：

MABPHARM-B 02181.HK approvement

2026-06-24

ETF
Bosera Szse Chinext Daily (2x) Leveraged Product (07234.HK) Falls 2.82% in Morning Trade, Turnover at HKD 5.0978 Million
ETF
E Fund (HK) Solactive Global Gold Miner Select Index ETF (02824.HK) Falls 1.95% in Morning Trade, Turnover at HKD 1.5859 Million
ETF
Global X Asia Semiconductor Etf (03119.HK) Falls 1.42% in Morning Trade, Turnover at HKD 4.3087 Million
ETF
CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.96% in Morning Trade, AUM at HKD 954 Million
ETF
Premia FTSE TWSE Taiwan 50 ETF (03453.HK) Falls 1.19% in Morning Trade, AUM at HKD 135 Million
ETF
CSOP SZSE CHINEXT ETF (03147.HK) Falls 0.86% in Morning Trade, AUM at HKD 592 Million
Finance
EuroEyes (01846.HK): Expected H‑1 Loss of HK$10 Million‑HK$17 Million
Finance
Jiaxin International Resources (03858.HK): Signs Bakuta Mining Construction Contract Worth Approximately RMB 257 Million
Finance
TCL Electronics (01070.HK): Proposes Spin‑off and Separate Listing of its Photovoltaic Business
Finance
Hengrui Pharmaceuticals (01276.HK): NDA for HRG2010 Capsules Accepted

Scan QR Code

Download App